Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Joseph Romanelli Returns To Merck To Lead Human Health International – $MRK $DIA

By John F. Heerdink, Jr.

Reportedly, Merck & Co., Inc. (MRK) announced that Joseph Romanelli will lead Human Health International, and join Merck’s Executive Team, effective August 1, 2022, and will directly report to Robert M. Davis, chief executive officer, and president, of Merck. In this role, Romanelli will have P&L responsibility for Merck’s $22 billion international human health business and lead a team of 14,000 colleagues in more than 75 markets outside of the U.S.

Romanelli led Merck’s business in China from 2016 through 2021, based in Shanghai, and returned to Merck after serving as chief executive officer of JiXing Pharmaceuticals, a China-based biopharmaceutical company, since 2021. 

“Joe’s remarkable track record of driving growth, unwavering commitment to keep patients at the center, deep knowledge of the global competitive landscape, and passion for Merck’s purpose to save and improve lives make him the ideal leader for our growing and expansive international Human Health business. I’m excited to welcome Joe back to Merck, and I am confident that our company and stakeholders will greatly benefit from his leadership, delivery, and contributions,” stated Robert M. Davis, chief executive officer, and president.

Merck & Co., Inc. (MRK) is a global healthcare solutions provider that has been working towards bringing forward medicine and vaccines for some of the world’s most challenging diseases for more than a century. They are committed to increasing health care access and continue to be at the leading edge of research. Merck has the industry’s largest immuno-oncology clinical research program. To learn more about Merck (MRK) and to track its ongoing progress please visit the Vista Partners Merck Coverage Page.

If you liked this story please consider, visiting the Atossa Therapeutics (ATOS) dedicated page at Vista Partners to learn about the Seattle-based biotech firm’s work towards finding therapeutic treatments for Breast Cancer and the Coronavirus. 

Stay Informed! Stay Competitive! Please join us at Vista Partners to receive our FREE email updates throughout the week and view our exclusive content and research. Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.

(Read Original Story: Merck Announces That Joseph Romanelli Will Lead Merck Human Health International, Effective August 1, 2022 in Business Wire)


Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us